venBio Sends Letter to Immunomedics Stockholders
Exelixis and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan
Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017
venBio Comments on Immunomedics Partnership Announcement
Top 10 High Growth Composite Material Market by Resin Type, Fiber Type, Application & Region - Global Forecasts to 2021 - Expected to Reach $105.26 Billion - Research and Markets
The lack of early success in its lead drug's cancer trial scares the market, but we see a buying opportunity.
Breakthrough Therapies: Market Dynamics and Investment Opportunities - Should Reach $99.2 Billion by 2022 - Research and Markets
Global Sealants and Sealant Applicators Technologies Market Report 2017-2021: $26.4 Billion Market Dynamics, Growth Drivers, Restraints, and Opportunities - Research and Markets
Lack of competitive advantages may mean these companies aren't the bargains they seem to be.
We see opportunity as fleeing investors trigger an irrational sell-off.